Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C
Clinical trial NCT00088504 · COMPLETED
Trial details
- NCT number
- NCT00088504
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.